Effects of Photobiomodulation on Asthma Immune Pathobiology: A Critical Review
Lasers in Surgery and Medicine · 23.08.2026
DOI: 10.1002/lsm.70193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 23.08.2026. Verfasst von Vipula Bataduwaarachchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. Die Arbeit nennt 116 Literaturangaben.
Abstract (Originalsprache)
Objective
This review investigates the potential of photobiomodulation (PBM) as a therapeutic option for asthma management and further examines the immune and molecular mechanisms that may support its therapeutic effects.
Methods
A comprehensive literature review was conducted in PubMed, Scopus, Google Scholar, EMBASE, Web of Science, CINAHL, and MEDLINE. A set of keywords covering the topic was used to extract relevant articles from 1990 to April 2026. The selected articles were used to synthesize a scientific narrative based on the critical analysis of extracted data, summarized in tables and illustrated in detail.
Results
Emerging data from preclinical and clinical evaluations demonstrate that PBM acts as a highly viable, non‐invasive therapeutic modality that counteracts the core immune‐mediated mechanisms driving chronic airway inflammation in asthma. In most experimental asthma models, radiant energies of 3J and 5J significantly mitigate the Th2‐dominated hypersensitivity response by suppressing critical Type 2 inflammatory cytokines, specifically interleukin (IL)‐4, IL‐5, and IL‐13, and by reducing eosinophil recruitment and goblet cell hyperplasia. Beyond standard immune modulation, PBM supports non‐immune structural tissue preservation by enhancing the expression of anti‐inflammatory, anti‐apoptotic, and antioxidant genes in epithelial, endothelial, and fibroblast cells, thereby reducing collagen deposition and alleviating subepithelial fibrosis. In clinical settings, supplementary near‐infrared light applications and laser acupuncture have demonstrated marked efficacy, significantly reducing asthma severity grades, daily/nocturnal symptoms, and exacerbations, while establishing substantial improvements in asthma control and lung function. The review further discusses potential limitations, safety considerations, and directions for future research.
Conclusions
PBM is a potentially affordable and relatively safe adjunct therapy for asthma, supported by preclinical evidence warranting further research. Important aspects such as dosimetry, irradiation geometry, tissue optics, and the realistic delivery of photons to intrathoracic airways are still underdeveloped and require carefully designed clinical trials. Future health economic studies to assess the comparative cost‐benefit of PBM are also warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
- Department of Research and Innovation, Portsmouth Hospitals University NHS Trust, Research Office, Portsmouth, UK.
- School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
ORCID-Profile: Vipula Bataduwaarachchi, Tharushi Rajapakshe, Amandi Gunasekara, Leon D'Cruz
Zitieren
APA
Bataduwaarachchi, V., Rajapakshe, T., Gunasekara, A., & D'Cruz, L. (2026). Effects of Photobiomodulation on Asthma Immune Pathobiology: A Critical Review. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.70193
Vancouver
Bataduwaarachchi V, Rajapakshe T, Gunasekara A, D'Cruz L. Effects of Photobiomodulation on Asthma Immune Pathobiology: A Critical Review. Lasers in Surgery and Medicine. 2026. doi:10.1002/lsm.70193
BibTeX
@article{Bataduwaarachchi2026,
author = {Bataduwaarachchi, Vipula and Rajapakshe, Tharushi and Gunasekara, Amandi and D'Cruz, Leon},
title = {Effects of Photobiomodulation on Asthma Immune Pathobiology: A Critical Review},
journal = {Lasers in Surgery and Medicine},
year = {2026},
doi = {10.1002/lsm.70193}
}
EUVIMED